Athira Pharma Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
LONA$4.47+1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $90,584 | $95,966 |
| Short-term investments | 56,835 | 104,378 |
| Unbilled grant receivable | — | 1,227 |
| Prepaid expenses and other current assets | 5,682 | 5,962 |
| Insurance recovery receivable related to legal settlement (Note 7) | 1,628 | — |
| Total current assets | 154,729 | 207,533 |
| Restricted cash | 631 | 420 |
| Property and equipment, net | 3,388 | 4,053 |
| Operating lease right-of-use asset | 1,049 | 1,263 |
| Long-term investments | — | 44,829 |
| Other long-term assets | 448 | 55 |
| Total assets | $160,245 | $258,153 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $129 | $2,501 |
| Accrued liabilities | 18,343 | 8,604 |
| Accrued legal settlement (Note 7) | 10,000 | 10,000 |
| Current operating lease liability | 368 | 326 |
| Total current liabilities | 28,840 | 21,431 |
| Operating lease liability, less current portion | 1,217 | 1,585 |
| Total liabilities | 30,057 | 23,016 |
| Stockholders' equity: | ||
| Common stock, $0.0001 par value; 900,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively; 38,172,603 and 37,877,387 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 4 | 4 |
| Additional paid-in capital | 439,739 | 428,623 |
| Accumulated other comprehensive loss | (349) | (1,956) |
| Accumulated deficit | (309,206) | (191,534) |
| Total stockholders' equity | 130,188 | 235,137 |
| Total liabilities and stockholders' equity | $160,245 | $258,153 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.